US 11168141
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 11168141 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K47/10, A61K47/549